Skip to main content
OpenTrials
Not Yet Recruiting

NCT Number: NCT06842043

AI-Assisted Chest X-Ray for Misplaced Endotracheal and Nasogastric Tubes and Pneumothorax in Emergency and Critical Care Settings

Background Advancements in artificial intelligence (AI) have driven significant breakthroughs in computer-aided detection (CAD) for chest X-ray imaging. National Taiwan University Hospital (NTUH) research team previously developed an AI-based emergency Capstone CXR system (MOST 111-2634-F-002-015-, Capstone project), which led to the creation of a chest X-ray module. This chest X-ray module has an established model supported by extensive research and is ready for direct application in clinical trials without requiring additional model training. This study will utilize three submodules of the system: detection of misplaced endotracheal tubes, detection of misplaced nasogastric tubes, and identification of pneumothorax.

Objective This study aims to apply a real-time chest X-ray CAD system in emergency and critical care settings to evaluate its clinical and economic benefits without requiring additional chest X-ray examinations or altering standard care and procedures. The study will evaluate the CAD system's impact on mortality reduction, post-intubation complications, hospital stay duration, workload, and interpretation time, alongside a cost-effectiveness comparison with standard care.

Methods This study adopts a pilot trial and cluster randomized controlled trial design, with random assignment conducted at the ward level. In the intervention group, units are granted access to AI diagnostic results, while the control group continues standard care practices. Consent will be obtained from attending physicians, residents, and advanced practice nurses in each participating ward. Once consent is secured, these healthcare providers in the intervention group will be authorized to use the CAD system. Intervention units will have access to AI-generated interpretations, whereas control units will maintain routine medical procedures without access to the AI diagnostic outputs.

Results The study was funded in September 2024. Data collection is expected to last from January 2025 to December 2027.

Conclusions This study anticipates that the real-time chest X-ray CAD system will automate the identification and detection of misplaced endotracheal and nasogastric tubes on chest X-rays, as well as assist clinicians in diagnosing pneumothorax. By reducing the workload of physicians, the system is expected to shorten the time required to detect tube misplacement and pneumothorax, decrease patient mortality and hospital stays, and ultimately lower healthcare costs.

Not Yet Recruiting

Trial opening soon.

Get Notified

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

National Taiwan University Hospital

Taipei, Taiwan, 100225

Location contact

Chu-Lin Tsai, Medical Doctor

CONTACT

[email protected]

+886-2-2312-3456 ext. 267684

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

for units:

  • Emergency critical care or intensive care units.
  • The units included the patients requiring chest X-rays due to endotracheal intubation, nasogastric tube insertion, or ventilator use with a risk of pneumothorax.

Exclusion criteria

for units:

  • The unit supervisor doesn't agree to participate in the trial.
  • The unit is unable to implement the AI-assisted system (e.g., no data connection or system support).

Inclusion criteria

for Patients:

● Patients who are adults and require chest X-ray due to one of the following conditions: endotracheal intubation, nasogastric intubation, or the use of a ventilator with the potential to cause pneumothorax.

Exclusion criteria

for Patients: Patients in isolation wards or pediatric

  • Patients in isolation wards.
  • Patients in Infant Intensive Care Unit

Treatment and study plan

AI-assisted model

Other

physicians will be authorized to access the AI model's predictions during patient care as an additional decision-making reference. These predictions will be generated in seconds and can help identify issues such as tube misplacement (e.g., nasogastric tube, endotracheal tube) and pneumothorax through AI analysis of CXRs, which will alert the physician to review the images.

Primary outcomes

  1. In-hospital Mortality

    Time frame: During the hospital stay, an average of 1 week

    The patient's survival is monitored after undergoing a chest X-ray until hospital discharge.

Secondary outcomes

  1. Length of Hospital Stay

    Time frame: During the hospital stay, an average of 1 week

    The time a patient spends in the hospital from admission to discharge, usually measured in days.

  2. Misplacement Detection Time

    Time frame: During the hospital stay, an average of 1 week

    Evaluates whether the AI system can reduce the time to detect misplaced catheters or pneumothorax, thereby improving the timeliness of clinical intervention.

Sponsors and collaborators

Lead sponsor

National Taiwan University Hospital

Other

Collaborators

  • Fu Jen Catholic University Hospital
  • Min-Sheng General Hospital
  • National Taiwan University

Registry information

Official study title

Clinical Effectiveness and Cost-Effectiveness of Real-Time Chest X-Ray Computer-Aided Detection System for Misplaced Endotracheal and Nasogastric Tubes and Pneumothorax in Emergency and Critical Care Settings

Important dates

Study start
2026
Primary completion
2027
Study completion
2027
First posted
Feb 24, 2025
Registry last updated
Mar 17, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.